Bergan Cardiology — Omaha, Nebraska

Bergan Cardiology is a clinical research site located in Omaha, Nebraska, United States 68124.

Crixeo Health Trust Score: 59/100 (POOR). This profile has not yet been claimed by the site owner.

Bergan Cardiology has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: In-Stent Restenosis, Atrial Fibrillation, Stroke.

Sponsors: Boston Scientific Corporation.

Sponsor Feasibility Report

Trust Score: 59/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Bergan Cardiology?

Bergan Cardiology has a Crixeo Trust Score of 59/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Bergan Cardiology conducted?

Bergan Cardiology has 2 clinical trials on record, with 2 currently active. Their work covers In-Stent Restenosis, Atrial Fibrillation, Stroke.

Is Bergan Cardiology accredited by Crixeo Health?

Bergan Cardiology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Bergan Cardiology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.